MRI disease activity significantly reduced with remibrutinib vs. teriflunomide in two trials, including reductions in T2 lesion activity by 65% and 70%, and Gd+ T1 lesions by 66% across both trials¹ ...

Wray Thorn appointed President and Chief Financial Officer; Harvey Schnitzer to transition to Director of Integration ...

Author-developed evidence chain adapts Lean Six Sigma Define and Measure logic to help practitioner researchers build ...

FFAI has announced that this week's Investor Weekly Report from FF Founder and Global CEO YT Jia has been rescheduled to ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

SEATTLE, Sept. 14, 2026 (GLOBE NEWSWIRE)-- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN ...

Twelve datasets and evaluation systems, built by hand from thousands of real-world security flaws, give model builders and enterprises a proven way to keep AI-generated code from introducing ...